InvestorsHub Logo
Followers 43
Posts 8463
Boards Moderated 3
Alias Born 11/23/2003

Re: None

Thursday, 05/25/2017 2:29:44 PM

Thursday, May 25, 2017 2:29:44 PM

Post# of 12410
***PKTX… A Few of you might have seen or stumbled over this article..Written back in January of 2007..
…The Cosmetic giant..L’Oreal was very, very interested in Protokinetix’s molecule..AAGP to use in their
Cosmetic Empire…. Protokinetix and L’Oreal had an agreement but as the story go…But L’Oreal wanted total control over the molecule..AAGP and the agreement went South and the companies parted ways..

http://www.cosmeticsdesign.com/Formulation-Science/ProtoKinetix-claims-breakthrough-in-anti-aging-research

As the story goes…L’Oreal must have liked what they saw.. I found these two articles on the research that L’Oreal
had funded two different companies to help develop their own type of “Our”(PKTX)Anti-inflammatory molecule.

http://www.cosmeticsdesign.com/Formulation-Science/Ground-breaking-anti-aging-discovery-from-Antarctic-fish-gets-L-Oreal-excited

http://www.cosmeticsdesign-europe.com/Formulation-Science/Industry-falls-in-behind-L-Oreal-s-investment-in-breakthrough-discovery-from-Antarctic-fish

…AFGPs have proven useful in many applications. However, they are limited by their cost (approximately $10,000/gram), instability, and size (2,600 - 24,000 Daltons). Their large size restricts their use in medicine as they are unable to pass through capillaries into interstitial tissue and are unable to reach target cells. Molecules must be less than 600 Daltons to diffuse through the capillaries. In addition, molecules must be less than 1000 Daltons to pass through cell junctions into neighbouring cells and less than 600 Daltons to cross the blood-brain barrier.

.....With these issues in mind Dr. Geraldine-Castelot-Deliencourt invented AAGP ™ to be a smaller, more stable synthetic version of AFGP.

***With that Question in mind…"WHY..PKTX’s Molecule…AAGP"..

..The Answer is(IMHO).. Because….It Works… :+O

....ProtoKinetix Patents:
USA

Patent Number: US 8,394,362B2

Granted: March 12, 2013

Expires: March 12, 2033